Abstract
Introduction Attributing a causative agent to acute febrile illnesses (AFI) remains a challenging diagnostic task for clinical and public health laboratories. The need for developing, validating and implementing a multi-pathogen diagnostic assay able to detect a wide range of AFI-associated pathogens should be prioritized in low-resource settings. The use of the previously developed Acute Febrile Illness TaqMan Array card (AFI-TAC), which detects 26 pathogens in less than 2 hours post-sample nucleic acid extraction, was selected for evaluation in Uganda.
Methods This was a cross-sectional retrospective study in which archived viral hemorrhagic fever (VHF)-negative blood and plasma samples were selected. Samples were previously tested and archived at the Uganda Virus Research Institute (UVRI)-Viral Hemorrhagic Fever (UVRI-VHF) Laboratory from August 2018 to March 2019 as part of the routine surveillance program. The VHF case definition included, temperature of ≥38.0 ºC, additionally with bleeding and any other febrile symptoms. Samples were then tested using an AFI-TAC for 35 potential pathogen targets. Selected positive samples were subsequently assessed using a second, pathogen-specific simplex PCR assay. Epidemiological data were linked to the laboratory findings to assess for risk factors for infection.
Results A total of 82 samples were selected for this study, of which 152 (83.52%) were from Uganda, 22 (12.09%) from the Democratic Republic of the Congo, 7 (3.85 %) from South Sudan, and 1 (0.55%) from Kenya. The median age of the patients was 27 years, with 145 (79.67%) samples from adults >18 years. Seven pathogens were detected with the most prevalent being Plasmodium spp. 26.92% (49/182) of which 69.4% (34/49) were Plasmodium falciparum, Yellow fever virus 2 (1.10 %), non-typhoidal Salmonella 3 (1.65%), Salmonella enterica serovar Typhi (1.10%), Leptospira spp. 1 (0.54%), Streptococcus pneumonia (0.55%), and Rickettsia spp. (0.55%). Epidemiological correlation revealed a significant relationship between case fatality (p=0.002) and disease while age, occupation, sex and disease were not significant. Cough was found to be the only clinical symptom associated with being infected with Plasmodium (p=0.016).
Conclusion The use of TAC is feasible, readily adoptable diagnostic assay for use in Uganda and will be useful when incorporated into the national testing algorithm for the differential diagnosis of AFI during an outbreak and surveillance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Uganda Virus Research Institute, the Viral Hemorrhagic Fevers program with support from the Centers for Disease Control and prevention
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the office of the Director General of Health services in the Ministry of Health Uganda.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
